(Q44485552)

3 December 2017

title

Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease (English)

1 reference

3 December 2017

1 reference

3

Hannia Campos

1 reference

3 December 2017

Sung-Joon Lee

1

1 reference

3 December 2017

Lemuel A Moye

series ordinal

2

1 reference

3 December 2017

Gordon H Williams

series ordinal

4

1 reference

3 December 2017

Frank M Sacks

series ordinal

5

1 reference

3 December 2017

publication date

1 April 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

167

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

293-302

1 reference

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Hyperinsulinemia and triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Apo C subclasses from non-insulin-dependent diabetic patients--a quantitative comparison with control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Lipoprotein Lipids and Apolipoproteins (AI, AII, B, CII, CIII) in Type 1 and Type 2 Diabetes Mellitus in Young Kuwaiti Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900007-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(03)00007-8

1 reference

3 December 2017

1 reference